Clorox Co. (CLX) Earnings Analysis

Clorox Co. (CLX) reported results in line with expectations in FY2026 on revenue of $116.6B versus the $115.4B estimate (-4.9% YoY) and EPS of $1.01. Below is the full Clorox Co. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Clorox Co. (CLX) Earnings Analysis — key stats

Latest reported quarterFY2026
Earnings verdictIn line
Revenue$116.6B (vs $115.4B est · +1.0% surprise · -4.9% YoY)
EPS$1.01 (vs $1.03 est · -1.9% surprise · -6.8% YoY)
Share price$381.28 (+0.9%)
Market cap$730.0B

What you'll find

Frequently asked questions

When is Clorox Co.'s next earnings date?
Magnisto tracks Clorox Co.'s (CLX) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did Clorox Co. (CLX) beat or miss earnings?
In FY2026, Clorox Co. (CLX) posted in-line results — revenue of $116.6B versus the $115.4B estimate (+1.0% surprise) and EPS of $1.01 versus $1.03 expected (-1.9% surprise). Magnisto decodes every Clorox Co. (CLX) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Clorox Co. (CLX) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Clorox Co. (CLX), anchored to the current $381.28 share price, so you can weigh the bull, base and bear cases for Clorox Co. side by side.
Is Clorox Co. (CLX) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Clorox Co. fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.